These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 18018541)

  • 1. [Prevention of cardiovascular risk in diabetes].
    Marre M; Duval-Leclercq M; Travert F
    Rev Prat; 2007 Sep; 57(13):1423-30. PubMed ID: 18018541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary prevention of cardiovascular events and type 2 diabetes: should we prioritize our interventions?
    Sultan A; Thuan JF; Avignon A
    Diabetes Metab; 2006 Dec; 32(6):559-67. PubMed ID: 17296509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of cardiovascular disease in patients with diabetes: role of hyperglycemia.
    Milicevic Z; Raz I; Beattie SD; Campaigne BN; Sarwat S; Gromniak E; Kowalska I; Galic E; Tan M; Hanefeld M
    Diabetes Care; 2008 Feb; 31 Suppl 2():S155-60. PubMed ID: 18227478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of postprandial hyperglycemia in cardiovascular disease.
    Fava S
    Expert Rev Cardiovasc Ther; 2008 Jul; 6(6):859-72. PubMed ID: 18570623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of glycemic treatment choices on cardiovascular complications in type 2 diabetes.
    Weiss IA; Valiquette G; Schwarcz MD
    Cardiol Rev; 2009; 17(4):165-75. PubMed ID: 19525678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in reducing the burden of vascular disease in type 2 diabetes.
    Chalmers J; Joshi R; Patel A
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):434-7. PubMed ID: 18307736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acetylsalicylic acid in patients with diabetes mellitus: can be used for secondary but not primary prevention of cardiovascular events].
    Klomp CM; ten Cate H; Stehouwer CD; Schaper NC
    Ned Tijdschr Geneeskd; 2009; 153():A109. PubMed ID: 19785798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension and diabetes mellitus are associated with cardiovascular events in the elderly without cardiovascular disease. Results of a 15-year follow-up in a Mediterranean population.
    Noto D; Cefalù AB; Barbagallo CM; Sapienza M; Cavera G; Nardi I; Pagano M; Vivona N; Notarbartolo A; Averna MR
    Nutr Metab Cardiovasc Dis; 2009 Jun; 19(5):321-6. PubMed ID: 18571394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twelve shifting paradigms in diabetic renal disease and hypertension.
    Mogensen CE
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S2-9. PubMed ID: 18947897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. For the majority of patients with diabetes blood pressure and lipid management is not in line with recommendations. Results from a large population-based cohort in Germany.
    Raum E; Lietzau S; Stegmaier C; Brenner H; Rothenbacher D
    Pharmacoepidemiol Drug Saf; 2008 May; 17(5):485-94. PubMed ID: 18383562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.
    Buse JB; Ginsberg HN; Bakris GL; Clark NG; Costa F; Eckel R; Fonseca V; Gerstein HC; Grundy S; Nesto RW; Pignone MP; Plutzky J; Porte D; Redberg R; Stitzel KF; Stone NJ; ;
    Circulation; 2007 Jan; 115(1):114-26. PubMed ID: 17192512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 2 diabetes mellitus: prevention of macrovascular complications.
    Meeuwisse-Pasterkamp SH; van der Klauw MM; Wolffenbuttel BH
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):323-41. PubMed ID: 18327994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary prevention of cardiovascular disease in people with dysglycemia.
    Bianchi C; Miccoli R; Penno G; Del Prato S
    Diabetes Care; 2008 Feb; 31 Suppl 2():S208-14. PubMed ID: 18227487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The benefit of aspirin therapy in type 2 diabetes: what is the evidence?
    Sirois C; Poirier P; Moisan J; Grégoire JP
    Int J Cardiol; 2008 Sep; 129(2):172-9. PubMed ID: 18495263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycemic targets for patients with type 2 diabetes mellitus.
    Hamnvik OP; McMahon GT
    Mt Sinai J Med; 2009 Jun; 76(3):227-33. PubMed ID: 19421966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diabetes and heart].
    Catargi B
    Nephrol Ther; 2006 Jan; 2 Suppl 1():S17-22. PubMed ID: 17378135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on diabetes mellitus: prevention, treatment, and association with oral diseases.
    Skamagas M; Breen TL; LeRoith D
    Oral Dis; 2008 Mar; 14(2):105-14. PubMed ID: 18302671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing diabetic complications: a primary care perspective.
    Zimmet P
    Diabetes Res Clin Pract; 2009 May; 84(2):107-16. PubMed ID: 19278746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fenofibrate for cardiovascular disease prevention in metabolic syndrome and type 2 diabetes mellitus.
    Steiner G
    Am J Cardiol; 2008 Dec; 102(12A):28L-33L. PubMed ID: 19084087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.